Literature DB >> 10791687

Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress.

T Brzozowski1, P C Konturek, S J Konturek, D Drozdowicz, R Pajdo, M Pawlik, I Brzozowska, E G Hahn.   

Abstract

Prostaglandins (PG) derived from COX-1 play an important role in the maintenance of mucosal integrity but the role of COX-2-derived products in mucosal defence mechanism has not been fully explained. Mild stress is known to prevent gastric mucosal lesions induced by severe stress via the phenomenon of adaptive cytoprotection but it remains unknown which COX is involved in this adaptation. In this study, the mucosal expression of COX-1 and COX-2 was examined and the inhibitors of these enzymes were used to determine the contribution of these enzymes in adaptive cytoprotection induced by mild stress. Male Wistar rats were exposed to mild water immersion and restraint stress (WRS) at various time intervals ranging from 5 min up to 2 h followed 1 h later by exposure to severe 3.5 h WRS with or without pretreatment with: 1) NS-398 (10 mg x kg(-1) i.g.), a selective COX-2 inhibitor; 2) resveratrol (5 mg x kg(-1) i.g.), a selective COX-1 inhibitor; 3) meloxicam (2 mg x kg(-1) i.g.), preferential COX-2 inhibitor; and 4) indomethacin (5 mg x kg(-1) i.p), non-selective inhibitor of COX. The number of WRS lesions was counted, gastric blood flow (GBF) was measured by H2-gas clearance technique, mucosal biopsy samples were taken for the assessment of PGE2 by radioimmunoassay, and the expression of COX-1 and COX-2 mRNA by RT-PCR. WRS for 3.5 h produced numerous gastric lesions, decreased GBF by 48% and inhibited formation of PGE2 by 68% as compared to intact mucosa. Exposure to mild WRS during 5-30 min by itself failed to affect mucosal integrity but significantly attenuated gastric lesions induced by exposure to severe 3.5 h stress; the maximal protective effect being achieved with mild WRS during 15 min. This protective effect was accompanied by the rise in GBF and the generation of PGE2 in the gastric mucosa. After extension of mild WRS from 15 min up to 1 or 2 h before more severe 3.5 h WRS, the loss of cytoprotective effect of mild WRS against severe stress accompanied by significant fall in the GBF were observed. Pretreatment with NS-398 (10 mg x kg(-1) i.g.) that failed to affect mucosal PGE2 generation, reduced significantly the protection and accompanying rise in GBF produced by mild WRS whereas resveratrol partly reduced the protection and the rise in GBF induced by mild WRS. Meloxicam or indomethacin significantly inhibited PGE2 generation and completely abolished the hyperemia and protection induced by mild WRS against more severe stress. The protective and hyperemic effects of mild WRS were completely restored by the addition of 16,16 dm PGE2 (5 microg x kg(-1) i.g.) to NS-398 or resveratrol, while the deleterious effects of meloxicam and indomethacin were significantly attenuated by the concomitant treatment with this PGE2 analogue. We conclude that PG derived from both, COX-1 and COX-2 appear to be involved in adaptive cytoprotection developed in response to mild stressors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10791687     DOI: 10.1016/s0928-4257(00)00145-5

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  9 in total

1.  5-Methoxyindole-2-Carboylic Acid (MICA) Fails to Retard Development and Progression of Type II Diabetes in ZSF1 Diabetic Rats.

Authors:  Chun-Yan Li; Wei-Xing Ma; Liang-Jun Yan
Journal:  React Oxyg Species (Apex)       Date:  2020-05-01

2.  Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.

Authors:  Alessandra Gambero; Marta Maróstica; Tagliane Liza Becker; José Pedrazzoli
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

3.  Preconditioning stress prevents cold restraint stress-induced gastric lesions in rats: roles of COX-1, COX-2, and PLA2.

Authors:  Akiko Tanaka; Ryo Hatazawa; Yuka Takahira; Nahoko Izumi; Ludmila Filaretova; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

Review 4.  A review on animal models for screening potential anti-stress agents.

Authors:  Amteshwar Singh Jaggi; Nitish Bhatia; Naresh Kumar; Nirmal Singh; Preet Anand; Ravi Dhawan
Journal:  Neurol Sci       Date:  2011-09-17       Impact factor: 3.307

5.  Octreotide ameliorates gastric lesions in chronically mild stressed rats.

Authors:  Noha N Nassar; Mona F Schaalan; Hala F Zaki; Dalaal M Abdallah
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

6.  Role of central and peripheral ghrelin in the mechanism of gastric mucosal defence.

Authors:  Tomasz Brzozowski; Peter C Konturek; Danuta Drozdowicz; Stanislaw J Konturek; Michal Pawlik; Zbigniew Sliwowski; Wieslaw W Pawlik; Eckhart G Hahn
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

7.  Protective effect of palm vitamin E and α-tocopherol against gastric lesions induced by water immersion restraint stress in Sprague-Dawley rats.

Authors:  Ibrahim Abdel Aziz Ibrahim; Kamisah Yusof; Nafeeza Mohd Ismail; Nur Azlina Mohd Fahami
Journal:  Indian J Pharmacol       Date:  2008-03       Impact factor: 1.200

8.  The Protective Role of Carbon Monoxide (CO) Produced by Heme Oxygenases and Derived from the CO-Releasing Molecule CORM-2 in the Pathogenesis of Stress-Induced Gastric Lesions: Evidence for Non-Involvement of Nitric Oxide (NO).

Authors:  Katarzyna Magierowska; Marcin Magierowski; Marcin Surmiak; Juliusz Adamski; Agnieszka Irena Mazur-Bialy; Robert Pajdo; Zbigniew Sliwowski; Slawomir Kwiecien; Tomasz Brzozowski
Journal:  Int J Mol Sci       Date:  2016-03-24       Impact factor: 5.923

9.  Hydrogen Sulfide and Carbon Monoxide Protect Gastric Mucosa Compromised by Mild Stress Against Alendronate Injury.

Authors:  Marcin Magierowski; Katarzyna Magierowska; Jakub Szmyd; Marcin Surmiak; Zbigniew Sliwowski; Slawomir Kwiecien; Tomasz Brzozowski
Journal:  Dig Dis Sci       Date:  2016-08-19       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.